Copyright
©The Author(s) 2024.
World J Gastroenterol. Nov 21, 2024; 30(43): 4609-4619
Published online Nov 21, 2024. doi: 10.3748/wjg.v30.i43.4609
Published online Nov 21, 2024. doi: 10.3748/wjg.v30.i43.4609
Figure 6 Frequency distributions of plasma SHOX2, RNF180, SEPTIN9, and EPO methylation before and after therapy in patients with esophageal cancer (n = 23).
Frequency distributions of plasma SHOX2, RNF180, SEPTIN9, and EPO methylation were less after therapy than before therapy.
- Citation: Liu XJ, Pi GL, Wang S, Kai JD, Yu HF, Shi HW, Yu J, Zeng H. Plasma DNA methylation detection for early screening, diagnosis, and monitoring of esophageal adenocarcinoma and squamous cell carcinoma. World J Gastroenterol 2024; 30(43): 4609-4619
- URL: https://www.wjgnet.com/1007-9327/full/v30/i43/4609.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i43.4609